Adam Koppel, EVP, Strategy and Business Development at BIOGEN INC. (BIIB), sold 555 shares at $290.00 ($161K) on 2016-06-06, disclosed to the SEC on 2016-06-07.
Open-market sale of $161k BIIB by EVP, Strategy and Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SWTX | SELL | 2021-03-11 | $103.7M | — | Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |